GlassScriptPhysician profile
Rachel Gilbert
NPI 1861955890
$846.88
in general payments reported to CMS, 2019-2025
14 companies · $548 in 2025
The $548 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.15 · 2023: $98.07 · 2024: $184 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $270.19 | 2024-2025 | Veozah |
| Dexcom, INC. | $161.27 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Pfizer INC. | $68.68 | 2024-2025 | |
| Millicent US INC | $58.28 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Mayne Pharma Commercial LLC | $52.99 | 2025 | |
| Hologic Sales and Service, LLC | $46.06 | 2021-2024 | Affirm Prone Biopsy System |
| Coopersurgical, INC. | $36.55 | 2025 | Paragard T 380a, Sos |
| Abbvie INC. | $31.85 | 2023 | |
| Organon LLC | $26.34 | 2023 | Jada System |
| Innovation Technologies INC | $24.94 | 2024 | Irrisept |
| Ascend Therapeutics US, LLC | $23.37 | 2023 | |
| Exeltis, USA INC. | $16.51 | 2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $15.90 | 2025 | |
| Meditrina | $13.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.